In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors
Accumulated evidence suggests that enhancing the endocannabinoid (eCB) tone, in particular of anandamide (<i>N</i>-arachidonoylethanolamine, AEA), has therapeutic potential in many human diseases. Fatty acid amide hydrolase (FAAH) is a membrane-bound enzyme principally responsible for th...
Main Authors: | Emanuele Criscuolo, Maria Laura De Sciscio, Filomena Fezza, Mauro Maccarrone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/1/48 |
Similar Items
-
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
by: Alessandro Deplano, et al.
Published: (2019-01-01) -
Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes
by: Natalia Battista, et al.
Published: (2007-07-01) -
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen
by: Alessandro Deplano, et al.
Published: (2020-01-01) -
Fatty Acid Amide Hydrolase in an Early Land Plant, Physcomitrella patens
by: Haq, Imdadul, et al.
Published: (2019) -
Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
by: Marta Baranowska-Kuczko, et al.
Published: (2021-05-01)